Home » Regions » Global News » University of Edinburgh, Biogen Idec partner

University of Edinburgh, Biogen Idec partner

Wednesday, July 24, 2013

The University of Edinburgh and Massachusetts-based biotech Biogen Idec have partnered to research multiple sclerosis and motor neurone disease and identify drug compounds for potential treatments. The initiative is funded by Biogen Idec, which develops therapies for neurological disorders and has a portfolio of treatments for patients with multiple sclerosis.

The three-year collaboration will combine the university’s experience in translational medicine, which develops laboratory discoveries into treatments for patients, with Biogen Idec’s experience in drug discovery and development. Clinicians and scientists based at Edinburgh BioQuarter will focus on neuroscience, stem cell research and regeneration.

Looking for more news, check out the new FREE CenterWatch Weekly!

The new FREE CenterWatch Weekly is your source of critical news, emerging trends, and business issues around everything in the rapidly changing clinical research marketplace. Check out our new CWWeekly page! Sign up today for your free email newsletter, update your bookmarks and check us out regularly! We look forward to bringing you the best news and information about clinical research in 2018!